Katzav’s laboratory was the first to report VAV1 overexpression in human neuroblastoma specimens, suggesting that when VAV1 is expressed in tissues other than hematopoietic tissues, it may be involved in cancer [55]. This evidence concerns the gene VAV1 and cancer.